Summary Cells from two adenocarcinomas, an adenoma and a metastatic node were isolated in soft agar. Expression of antigens, CEA, Y haptenic blood group and 791T-p72, defined by a range of candidate antibodies for tumour targeting was assessed.
Colorectal carcinoma is one of the most common malignant neoplasms, yet, in spite of significant advances in surgical techniques, the survival rate has not improved over the past two decades (Silverberg, 1983; Stower & Hardcastle, 1985) . The major reasons are the advanced stage of the majority of colorectal carcinomas at presentation and that anticancer drugs have proven largely ineffective against the disseminated disease (Moertel, 1973) .
Monoclonal antibodies recognising antigens expressed selectively on human tumours are currently being evaluated in this laboratory for targeting conventional and novel anticancer drugs and toxins to colorectal carcinoma (Garnett et al., 1983; Pelham et al., 1983; Gallego et al., 1984) . However due to the heterogeneity of tumours (Brattain et al., 1984; Edwards, 1985; Armitage et al., 1984) it is essential to determine antigen expression on the target colorectal tumour cells. Overall tumour antigenicity has been studied on disaggregated cells from primary tumours and on cryopreserved tumour tissue sections (Finan et al., 1982; Primus & Goldenberg, 1982; Durrant et al., 1985) . However as it is stem cells which maintain the primary tumour and invade and seed in metastatic sites (Steel, 1977) it is important to study selectively their antigenicity. Any effective immunotherapy must be directed against the tumour stem Correspondence: L.G. Durrant. Received 22 May 1985; and in cells if recurrence or dissemination of the primary disease is to be prevented.
Cells have therefore been isolated from colorectal tumours and their expression of antigens defined by a range of candidate antibodies for tumour targeting has been assessed. Proliferative capacity, DNA content and tumourigenicity have also been studied. All of the clones bound at least three monoclonal antibodies although there was considerable variation in the quantity and stability of each antigen. They were all aneuploid and formed tumours in athymic mice.
Materials and methods

Clinical specimens
Specimens from primary colorectal cancer and infiltrated lymph nodes were obtained from surgically resected specimens. Tumour cell suspensions were prepared from tissue within 18 h of removal. Tissue was finely minced and placed in 0.05% collagenase (Boehringer, Mannheim, West Germany) Primary culture and passage Five percent agar stock was prepared by dissolving 0.5 g of bacterio Agar (Difco, Detroit, MA, USA) in 10 ml of sterile distilled water and autoclaving for 15min at l5p.s.i.
Freshly disaggregated tumour cells (105) were plated in 0.3% agar over an underlay of 0.5% agar, both diluted with 20F DMEM, in a 24 well plate (Costar, Cambridge, MA, USA). Cells were incubated for 3-4 weeks at 37°C when large colonies were observed. They were picked, dispersed in 20F DMEM and plated into 24 well plates. When they had formed confluent monolayers they were removed by vigorous pipetting and transferred to flasks (Falcon, Becton Dickinson, Oxnard, CA, USA). After several passages in flasks it became necessary to use 0.25% trypsin/EDTA (Flow, Irving, Fife, UK) to produce single cell suspensions.
Cells in bulk culture were routinely passaged twice weekly by detachment with 0.25% trypsin/EDTA and reseeding in 25cm3 or 75cm3 T flasks at -106 cells. Plating efficiencies of the proliferating cells were determined in soft agar as described above but only 200 cells/well were plated or by attachment of a similar number of cells to 1 ml plastic plates (Sterilin, Middlesex, UK). After 10-14 days agar colonies were counted microscopically and adherent colonies were fixed in 95% methanol and stained with 0.1% crystal violet. Doubling times were calculated by seeding cells at 104, 105, and 106ml-P in liquid culture and counting the cell number daily for 10 days. Monoclonal (Embleton et al., 1981; Price et al., 1983) . C14/1/46/40 antibody recognises a difucosylated type 2 blood group antigen (Brown et al., 1983) . It is expressed on the majority of colon adenocarcinomas and colon adenomas (Brown et al., 1984) . C24/1/39/11 antibody recognises an epitope expressed on CEA and NCA (Price et al., 1985) .
Indirect immunofluorescence Cells were stained by indirect immunofluorescence (Durrant et al., 1984) and analysed on a FACS IV (Becton Dickinson, Sunnyvale, CA, USA). Fluorescein fluorescence was excited at 488 nm and collected via a 10nm band width band pass filter centered at 515nm after adjustment for standard conditions using fluorochrome labelled latex beads. Fluorescence intensity is expressed as a mean channel number (mean linear fluorescence -MLF), calculated by multiplying the contents of each channel by its channel number and dividing by the total number of cells in the distribution (Roe et al., 1985) . Each cell line was also stained using normal mouse Ig, and the MLF in this control was subtracted from the values obtained with monoclonal antibody. In order to determine intraclonal variation 25% of the low and 25% of the high fluorescing cells were excluded and the range over which the remaining 50% of the cells were distributed is defined. It was impossible to define the standard deviation as the majority of distributions were non Gaussian.
Karyotypic analysis
Two hours after addition of colcemid (0.5ygml-1; Grand Island, Biological Co.) cells were removed by vigorous pipetting and incubated in 0.075 M KCI at room temperature. Ten minutes later they were fixed with 25% glacial acetic acid in anhydrous methanol. Slides were stained with 10% Giemsa (BDH, Poole, Dorset, UK) and the karyotypic pattern determined by studying 50 metaphase spreads.
DNA analysis Cells were pelleted and resuspended in 50 jl of 0.2% Triton X-100 (BDH, Dorset, UK) in 0.1 M NaCl at room temperature. After 1 min, 200,l of mithramycin (93.1 jg ml -1: Sigma, Dorset, UK) and 200Il of ethidium bromide (37.5pgml-1:
Sigma, Dorset, UK) were added and incubated at 40C prior to analysis on a FACS IV. Fluorescence was excited using 457nm light, and collected via 520 nm long pass filters.
The Figure la-f) .
Numerous colonies grew from the adenoma but to ensure successful transfer to adherent growth they were picked simultaneously and grown as a single culture. They expressed a large quantity of the Y haptenic blood group antigen, a significant amount of the 791T-p72 but only a low level of CEA/NCA (Table II) . The expression of all 3 antigens decreased upon prolonged culture.
Several colonies grew from 168 primary adenocarcinoma but only two continued to grow when transferred to costar plates. One of these clones bound a moderate level of C14/1/46/10 and 791T/36 but only a very small amount of C24/1/39/11 in direct contrast to binding of these monoclonal antibodies to the disaggregated cells of the primary tumour (Table I) . By passage 30 it expressed all three antigens weakly and by passage 40 they had stopped dividing.
The metastatic node derived tumour cells from patient 168 grew well in soft agar. Eight colonies were picked and grown as independent clones, the rest were pooled and grown simultaneously. This (Table I ). The clones expressed large variations in C14/1/46/10 expression (MLF 308-3516), but moderate levels of C24/1/39/11 (MLF 62-235) and 791T/36 (106-414) . A gradual loss of all 3 antigens was associated with passage number. Figure 1 (a-f) illustrates the loss in antigen expression between passages 3 and 30 for all of the cell lines. There appeared to be a gradual normalisation of expression for all three antigens. There was also enormous intraclonal variation in antigen expression particularly for the C14/1/46/10 defined epitope (Table II) . This variation was apparent even after only 3 in vitro passages and clearly (Table   III ). All the lines also grew well in agar provided they were supplied with 10% autologous conditioned medium. Plating efficiencies in agar ranged from 67-89% (Table III) . Similar plating efficiences were observed when the clonogenic cells were plated at low density, i.e. 200 cells/plate in liquid culture containing 10% autologous conditioned medium (Table III) . aPlating efficiency is defined as the number of colonies divided by the number of cells plated.
DNA content
All of the cell lines had aneuploid chromosome contents, C146 contained one extra chromosome, C170 two and C168 four. These chromosome perturbations were reflected in the relative DNA indices although this level of resolution was at the limits of the FACS IV cell sorter. The DNA contents of these cell lines did not correlate with the similar measurements on their primary tumours. Tumours C146 and C170 were diploid with no evidence of an aneuploid peak whereas tumour 168 contained a highly aneuploid population (DNA index= 1.8) composed of 35% of the tumour cells. Tumourigenicity Each line formed xenografts in athymic mice from s.c. inocula of 5 x 105 cells. It required 2-3 weeks to form tumours of volume 1 cm3. Subsequent grafting of these tumours into 8 mice took 2 weeks for tumours of 1 cm3 to reform.
Xenograft tumours were resected following 2 passages in mice and disaggregated in 0.05% collagenase and then analysed for antigenicity and growth potential (Table IV) . Similar levels of antigen expression and DNA content were observed in the xenograft derived cells to the corresponding cells maintained in liquid culture. Slightly higher doubling times were observed for all the xenograft derived cells when they were originally reestablished in liquid culture but after several Imaging of two mice with xenografts of the C170 tumour 2 to 5 days after injection of "'In-labelled antibody showed clear localization of radioactivity in tumours (Figure 3) . Thus tumour to non-tumour ratios of radioactivity of up to 4.6: 1 were achieved, the counts in the tumour region being up to 18% of those in the whole mouse. 
CU
The term 'stem cell' describes a cell with the ability to generate a large family of descendants within its natural environment. These descendants can be By passage 3 there were sufficient cells to stain with the monoclonal antibodies and analyse on a cell sorter. All of the cells bound high levels of C14/1/46/10 but only low levels of C24/1/39/11. There was an enormous interclonal heterogeneity with MLFs for C14/1/46/10 ranging from 197-3516. A rapid generation of intraclonal heterogeneity was also observed suggesting that dividing tumour cells have an enormous capacity for altering their surface phenotype. The heterogeneity of human colorectal cancer has been well documented (Brattain et al., 1984) . Studies on colorectal cell lines have illustrated that this heterogeneity is also observed in vitro (Brattain et al., 1984; Rosenthal et al., 1977; Drewinko et al., 1984; Dexter et al., 1981) . The wide variation in antigen expression on dividing cells from the same tumour implies that this heterogeneity is also probably expressed at the stem cell level although caution must be exerted at extrapolating directly from dividing cells in vitro to stem cells in vivo. Preferential regrowth of tumours by stem cells expressing low antigen levels may therefore occur following antibody mediated drug cytotoxicity and emphasises the need for a 'cocktail' of monoclonal antibodies recognising non associated antigens. There was no positive correlation between expression of the three monoclonal antibodies for any of the cells studied. In fact, many cells which expressed low levels of CEA expressed very high levels of the Y haptenic blood group antigen.
Prolonged culture of the cells produced further antigenic variation. Although in the majority of clones this was due to a reduction in expression of all 3 antigens, several clones showed enhanced binding of C14/1/46/10 monoclonal antibody. A similar drift in cell surface properties of tumour cells in vitro was noted by Neri et al., (1981) and is a problem when designing model systems for testing the cytotoxicity of drug-antibody conjugates.
All of the cell lines had abnormal karyotypes which were reflected in their DNA indices obtained by flow cytometry. A similar observation was described by Drewinko et al. (1984) , who subdivided colorectal cell lines on their DNA content, morphological differentiation, tumourigenicity, growth in soft agar and in tissue culture and on their levels of secreted CEA. Cell lines C146 and C170 could be ascribed by similar criteria to group I and C168 to group II. Growth of cells with abnormal DNA contents from tumours C146 and C170, which had diploid DNA contents, was particularly interesting. The clonogenic cells may all be aneuploid but comprise such a small proportion of the whole tumour they were undetected by the initial flow cytometric analysis. The aneuploid stem cells may preferentially grow in soft agar or short term tissue culture may induce chromosomal abnormalities. However, although 168 cells were aneuploid their DNA index was less than observed for the primary tumour suggesting that tissue culture may also cause chromosome segregation.
As all of the clonogenic cells grew readily in athymic mice without alteration in antigenicity and at least one monoclonal antibody, 791T/36, localised efficiently within these xenografts, they should be a good model for studying in vivo effects of drug-antibody conjugates.
It was surprising that an adenoma grew so readily in soft agar and that the isolated clones grew as vigorously as the carcinoma derived clones. However, the ability of these cells to form tumours in athymic mice and their aneuploid DNA content suggests that the adenoma contained a small malignant foci undetected histologically.
In the context of in vivo localisation of monoclonal antibodies it has already been established that radiolabelled 791T/36 antibody localises in primary or metastatic human colorectal tumours (Farrands et al., 1982; Armitage et al., 1984) , but the intratumoral site of production and/or expression of the antigen was previously poorly defined. As immunohistology with 791T/36 antibody showed reactions primarily in tumour stromal elements and pseudoacini contents rather than malignant cell surfaces (Armitage et al., 1983) . The present studies have demonstrated that the antigen defined by 791T/36 monoclonal antibody is produced by cells grown in vitro from colorectal tumours. In addition the growth of these clonogenic populations in nude mice provides xenograft tumour models for experimental studies on localisation of 791T/36 antibody for diagnostic or therapeutic application.
This study therefore demonstrated that colorectal tumours with high growth potential in vitro express a range of tumour associated antigens, several at higher levels than observed in the primary tumour. Careful selection of monoclonal antibody 'cocktails' should therefore allow antibody mediated drug cytotoxicity to be effective at eradicating rapidly dividing tumour cells. 
